Real Money authors - Bruce Kamich

Bruce Kamich

Bruce Kamich is TheStreet's in-house technical analyst with a 43 year career with a number of bulge bracket firms like Morgan Stanley, Smith Barney Harris Upham, and Merrill Lynch. Along the way he accumulated knowledge about the fundamentals of the commodity markets, interest rates, equities and ETFs. 

In addition to writing for Kamich has been teaching technical analysis at Baruch College for the past twenty years.

Kamich was one of the earliest Chartered Market Technicians  or CMTs, a professional designation similar to the CFA title. He has authored two books on charting and technical analysis - "How Technical Analysis Works"  and "Chart Patterns." He is a two-time past president of the Market Technicians Association (now called the CMTA), the professional organization for chartists worldwide. He was also the president of the Market Technicians Association Educational Foundation (
Email Bruce Kamich

Recent Articles By The Author

ATI Is Poised for Further Gains

Let's see where the charts are headed and we also have a new price target range.

Constellation Brands: Buying Opportunity or Start of a Downtrend?

Interestingly, TheStreet's Quant Ratings service upgraded its rating on STZ Friday.

Dow's Trading Needs to Pick Up to Support Its Advance

Let's take a look at the charts and indicators.

ArcelorMittal: A Tale of (at Least) Two Charts

Let's check out the charts and indicators for this steelmaking giant.

Lockheed Martin Appears Headed for a Pullback

Here's what to avoid for now.

How Is JPMorgan Chase Lining Up as Bank Earnings Approach?

We're checking the charts ahead of the bank's upcoming earnings report.

Walmart Shares Are Looking Vulnerable to Further Weakness

The challenges facing WMT as well as other retailers may be too much for them to handle.

Walgreens Could Continue to Weaken

The company reported earnings and the shares have rolled over and turned down.

No Silver Lining for 'Crypto Bank' Silvergate Capital's Charts

After announcing a fine and big layoffs, SI deserves to have its charts reviewed.

NovoCure Gaps Sharply Higher for a Breakout: How to Play It

Let's check out the charts and indicators of both NovoCure and Zai Lab.

Email sent

Thank you, your email to has been sent successfully.


We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight